Cambridge Investment Research Advisors Inc. Acquires 627 Shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)

Cambridge Investment Research Advisors Inc. grew its holdings in iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Rating) by 2.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 29,579 shares of the company’s stock after acquiring an additional 627 shares during the quarter. Cambridge Investment Research Advisors Inc. owned 0.48% of iShares Genomics Immunology and Healthcare ETF worth $745,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of IDNA. Vigilant Capital Management LLC bought a new position in iShares Genomics Immunology and Healthcare ETF in the fourth quarter worth $25,000. Westside Investment Management Inc. lifted its holdings in shares of iShares Genomics Immunology and Healthcare ETF by 200.0% during the third quarter. Westside Investment Management Inc. now owns 1,050 shares of the company’s stock valued at $21,212,000 after acquiring an additional 700 shares during the period. Credit Suisse AG bought a new position in shares of iShares Genomics Immunology and Healthcare ETF during the second quarter valued at $40,000. Flow Traders U.S. LLC bought a new position in shares of iShares Genomics Immunology and Healthcare ETF during the third quarter valued at $303,000. Finally, Janney Montgomery Scott LLC bought a new position in shares of iShares Genomics Immunology and Healthcare ETF during the fourth quarter valued at $1,025,000.

iShares Genomics Immunology and Healthcare ETF Stock Performance

Shares of NYSEARCA IDNA opened at $24.75 on Tuesday. The stock has a market cap of $153.45 million, a PE ratio of 10.95 and a beta of 0.90. The business has a fifty day moving average of $23.68 and a two-hundred day moving average of $25.31. iShares Genomics Immunology and Healthcare ETF has a 52-week low of $22.09 and a 52-week high of $34.66.

About iShares Genomics Immunology and Healthcare ETF

(Get Rating)

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.